Molecular Characterization for Understanding Biliary Atresia

Recruiting now · Not applicable

Conditions studied: Biliary Atresia

In brief

Although considered a rare disease, Biliary Atresia (BA) is the leading cause of neonatal cholestasis and liver transplantation in children. Little is known about the molecular mechanisms that drive BA. The purpose of this study is to collect the fluid samples, explanted liver tissue samples and dermal biopsy samples to enable investigators to perform the genetic and molecular analyses that might point to the gene(s) and cellular pathway involved in etiology of BA disease.

Key facts

Study ID

NCT04272515

Run by

Institut National de la Santé Et de la Recherche Médicale, France

People needed

100

Starts

2021-02-07

Expected to finish

2032-02-07

Last updated by the study team

2026-07-22

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• confirmed diagnosis of biliary atresia in patients
• parents of BA patients

You may not qualify if…

• no

Where it is running

• Hopital Necker enfants malades — Paris, De, France (enrolling)
• PRC Inserm — Paris, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.